Navigation Links
GeoVax Secures $10 Million Financing Commitment
Date:5/12/2008

.

About Fusion Capital

Fusion Capital Fund II, LLC is an institutional investor based in Chicago, Illinois with a fundamental investment approach. Fusion Capital invests in a wide range of companies and industries emphasizing life sciences, energy and technology companies. Its investments range from special situation financing to long-term strategic capital.

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
2. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
3. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
4. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
7. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
8. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
9. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
10. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
11. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...OandSTAFA,Switzerland,Nov.25/PRNewswire/-- FromNov...vehearingsolutions,presentedthesecondeditionoftheH...needsoftheolderpopulation.Theconferencebroughttoge...worldandmorethan250clinicianswhoworkeverydaywithol...eriencesanddiscussthelatestresearchandtrendsinhear...
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 1PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 2Warner Chilcott Completes Acquisition of P 26amp 3BGs Global Branded Prescription Pharmaceuticals Business 5871 1Warner Chilcott Completes Acquisition of P 26amp 3BGs Global Branded Prescription Pharmaceuticals Business 5871 2NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 1NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 2NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 3NeoStem Acquires China Biopharmaceuticals Holdings Inc 3B Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company 5869 4
...ne, Inc. (NYSE Amex: PIP ), a biodefense company...ical and chemical threats, announced today that ne...esented at the Keystone Symposia on Molecular and ...rch 29-April 3, 2009 in Banff, Alberta. , , The...or of Medicine and Dr. Subhendu Basu, Research Ass...
...Rx Pharmaceuticals, a privately-held biopharmaceut...d enrollment in the Company,s second pivotal Phase...ets). Together with the previously completed first...y has fully enrolled its planned pivotal Phase 3 s...n-free oral therapy currently in development for t...
Other Medicine Technology:Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 2Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 3Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 4Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 5Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 6QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/25/2009)...o.,Nov.25/PRNewswire/--TheBartleHallConventionCent...iniconDec.9-10,whenKansasCityhoststhelatestinaseri...hisfreecliniceventhasthepotentialtobethebiggestone...andbeheldonweekdaysinsteadofoveraweekend,"SheriWoo...andpresidentoftheNationalAssociationofFreeClinics(...
(Date:11/25/2009)...,Md.,Nov.25/PRNewswire-USNewswire/--AnarticlebyJan...luationandResearch,titled"ADifficultBalance-PainMa...2009issueofTheNewEnglandJournalofMedicine. ,, (.../FDALOGO ) ,, Inthearticle,WoodcockdiscussesFDA...onforthosewhoneeditandmanagingtherisksposedbyvario...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)... Evaluation and treatment clinics to resume M...k (Vocus) November 25, 2009 -- Centegra Health Sys... H1N1 vaccine shots at four Centegra Primary Care ...f vaccine has arrived. The clinics are at CPC site...and will be open as follows: ,   From ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...s Ability to Treat Subcutaneous Infections , , EM..., Inc. (NYSE Alternext: NBY), a clinical stage bio...reclinical data related to NVC-422, the lead molec...an Francisco during March 6-10, 2009. NovaBay is ...
...evier,world-leading publisher of scientific, techn..., is pleased to announce the July 2009 launch of a...with the American College of,Osteopathic Family Ph...sicians, is designed to deliver information that h...
...k logged on to www.WorldMedAssist.com to help hi...recommended. Just three weeks later, he was out o...ompleted. He,s now home and enjoying his new leas...em with his heart,s mitral valve, he had no idea h...
...ded family law attorney among just five percent of...s professional designation , ...ruce Chase , a respected Hackensack, N.J. attorney...wyers magazine as one of the top attorneys in the ...
...ations of pharmaceutical drugs and endocrine-disru... are likely too low to impact human health, accord...on, the nation,s leading drinking water research o...nds found in our public drinking water are likely ...
...ical cancer may direct more women to optimal thera...m morbidity and complications of trimodality thera... to a study performed at the Institute for Technol...t imaging with MRI and/or PET/CT in patients with ...
Other Medicine News:Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 2Health News:NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting 3Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 2Health News:Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians 3Health News:Ohio Patient Thanks India and WorldMed Assist For Heart Surgery Overseas; His Indian Surgeon Thanks U.S. for Superb Training 2Health News:Ohio Patient Thanks India and WorldMed Assist For Heart Surgery Overseas; His Indian Surgeon Thanks U.S. for Superb Training 3Health News:Hackensack Lawyer Bruce E. Chase Named New Jersey Super Lawyer for Third Consecutive Year 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 2Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 3Health News:Levels of Trace Pharmaceuticals in Drinking Water Too Low to Impact Human Health According to Water Research Foundation Study 4Health News:MRI and PET/CT improve cervical cancer patient's chances for optimal treatment 2
AST (SGOT) Reagent (Colorimetric, Endpoint Procedure)
AST-GOT
...-line worker" for routine staining protocols frequ...s. It automatically stains big quantities of slide...of reagent stations in combination with a continuo...p to 12 baskets with 30 slides each can be process...
MS/DS 50/100 Slide Stainer
Medicine Products: